by PEAK Medicals | 6 November 2024
UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in Antibody Drug Conjugates Giuseppe Banna Portsmouth Hospitals NHS Trust, UK Alessandra Curioni Cantonal Hospital Fribourg,...
by PEAK Medicals | 26 September 2024
UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in Gynecological Cancers Apostolos Sarivalasis Lausanne University Hospital, Switzerland Ilaria Colombo oncology institute of...
by PEAK Medicals | 2 July 2024
Breast Cancer (ASCO 2024) Welcome & introduction by host Jens Huober Latest treatment updates in early breast cancer Konstantin Dedes How does the latest ASCO data integrate into the treatment of TNBC and HER2+ advanced breast cancer? Isabell Witzel Where do we stand...
by PEAK Medicals | 30 April 2024
HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
by PEAK Medicals | 13 December 2023
Breast Cancer 2023 Review Welcome & introduction by host Peter Dubsky Early breast cancer and local therapies Peter Dubsky Latest advances with antibody-drug conjugates and immunotherapies Nadia Harbeck Highlights of 2023 in endocrine and combination therapies Khalil...
